BioCeuticals Clinical Oestro-BR 60t

Description

Metabolising Complex with Standardised BroccoRaphanin®
Herb and nutrient formula for detoxification and antioxidant support, with 20mg glucoraphanin per tablet.
Oestro-BR contains a blend of herbs and nutrients designed to support healthy liver function and detoxification, as well as providing antioxidant support. The formula features BroccoRaphanin®, a broccoli extract standardised to glucoraphanin, which is metabolised to the compound sulphoraphane.

• Features BroccoRaphanin®, a broccoli extract standardised to glucoraphanin.
• Isothiocyanates may function as antioxidants via phase 2 enzyme induction.
• Rosemary provides antioxidants which may help protect cells from oxidative damage.
• Grape seed is a source of antioxidants, which may provide the body with protection against free radical damage.
• Bupleurum is used in traditional Chinese medicine (TCM) for soothing the liver and menstrual regularity.
• Molybdenum plays a role in activity of enzymes involved in detoxification.
• Methionine helps to support liver function.
• Rosemary is traditionally used in western herbal medicine (WHM) for symptomatic relief of dyspepsia, including digestive spasms.
• Vegan-friendly formula.

 

Each tablet contains:
Herbal extract standardised equiv. to fresh:
Brassica oleracea var. italica (broccoli) seed - BroccoRaphanin®	300mg
equiv. to allyl isothiocyanate	0.6mcg
Herbal extracts equiv. to dry:
Rosmarinus officinalis (rosemary) leaf	1g
equiv. to cineole	725mcg
equiv. to camphor	680mcg
Bupleurum falcatum (bupleurum) root	1g
Vitis vinifera (grape seed) seed	533mg
equiv. to procyanidins	4.2mg
Nutrients:
Methionine	25mg
Molybdenum trioxide	62.5mcg
equiv. molybdenum	41.7mcg

 

No added dairy, gluten, shellfish, soy protein, yeast.
Vegan & vegetarian friendly.

If symptoms persist consult your healthcare professional.
Always read the label. Use only as directed.

Prescribing Information:
There is insufficient reliable information available about the safety of broccoli sprout extract, grape seed, rosemary and bupleurum during pregnancy; avoid using.
Molybdenum is generally well tolerated, although it can form complexes with copper, decreasing the absorption of both minerals a beneficial effect in patients with copper excess. Copper deficiency due to molybdenum intake is unlikely however, although individuals with low copper intake or dysfunction of copper metabolism may be at increased risk.
Patients with elevated uric acid levels or gout should limit molybdenum to 75mcg per day.
Saikosaponins from bupleurum may inhibit platelet aggregation. Theoretically, bupleurum may increase the risk of bleeding when used concomitantly with anticoagulant/antiplatelet drugs.
Saikosaponins from bupleurum may increase blood glucose levels. Theoretically, bupleurum may interfere with blood glucose control when used concomitantly with diabetes drugs.
Bupleurum may stimulate immune function and interfere with immunosuppressive therapy.
There is preliminary evidence that rosemary may inhibit platelet aggregation. Theoretically, rosemary may increase the risk of bleeding when used concomitantly with anticoagulant/antiplatelet drugs.
In vitro evidence shows that grape seed may inhibit platelet aggregation. Theoretically, grape seed may increase the risk of bleeding when used concomitantly with anticoagulant/antiplatelet drugs, although this has not been reported in humans.
In vivo research suggests broccoli may induce cytochrome P450 1A2 (CYP1A2) and 2A6 (CYP2A6) activity, theoretically increasing the metabolism of, and reducing the levels of drugs metabolised by these enzymes.